Markets
Stocks
Mutual Funds & ETF's
Sectors
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TEKMIRA PHARM
(NQ:
TKMR
)
4.760
USD
-0.020 (-0.42%)
Streaming Delayed Price
/ Updated:
3:04 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
22,100
Open
4.750
Bid (Size)
4.700 (2000)
Ask (Size)
4.720 (100)
Prev. Close
4.780
Today's Range
4.680 - 4.780
52wk Range
1.860 - 6.780
Shares Outstanding
14,388,215
Dividend Yield
N/A
Top News
More News
Maxim Group Starts Tekmira Pharma (TKMR) at Buy
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8427662 for the full story.
Read More
from
StreetInsider.com News Articles
Tekmira Announces Election of Directors
May 17, 2013
from
GlobeNewswire News Releases
More News
Read More
Tekmira Presents LNP Technology Innovations at Scientific Symposium
May 15, 2013
from
GlobeNewswire News Releases
Tekmira Provides Corporate Update and Announces First Quarter 2013 Results
May 14, 2013
from
GlobeNewswire News Releases
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results
May 09, 2013
from
GlobeNewswire News Releases
Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program
May 08, 2013
from
GlobeNewswire News Releases
Early-Stage Clinical Data Highlights from AACR 2013
April 16, 2013
category
DMPI
,
ARQL
,
TKMR
, and 2 more.
from
Bio-Wire.Com
Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR)
April 10, 2013
from
GlobeNewswire News Releases
Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting
April 09, 2013
from
GlobeNewswire News Releases
Zacks Analyst Grant Zeng: 6 Biotechs with Staggering Potential
April 04, 2013
category
PBIO
,
NEO
,
TKMR
, and 4 more.
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here